Pāriet uz saturu
Cilvēka saphena vēnas endotēlija šūnas (HSVEC)
Audums
Saphenous vein
Slimība
Normal saphenous vein endothelium (primary cells; non-tumorigenic)
Metastāžu vieta
Not applicable (normal, non-tumorigenic primary cell)
Sinonīmi
HSaVEC, HSVEC, Human saphenous vein endothelial cells, provitro 1210121

Dokumenti

Cilvēka saphena vēnas endotēlija šūnas (HSVEC)

Primary cell · Preces numurs 300699

Venous endothelium for bypass graft research

€1,220.00bez nodokļa un piegādes izmaksām

Pielāgošana / Ieteikumi

Pēc pasūtījuma
1

01Vispārīga informācija

Apraksts

Primary Human Saphenous Vein Endothelial Cells (HSaVEC) are isolated from the saphenous vein and offer a venous endothelial model alongside HUVEC. They are used in research on atherosclerosis, leukocyte adhesion and the endothelial failure of coronary bypass vein grafts.

HSaVEC show the typical cobblestone morphology and express CD31 and VE-cadherin. As cells from adult vessels, they differ from fetal HUVEC: they are more sensitive to oxidized LDL, respond less strongly to cytokines and can present antigen to T cells, making them a closer model of adult venous endothelium.

Audums
Saphenous vein
Slimība
Normal saphenous vein endothelium (primary cells; non-tumorigenic)
Metastāžu vieta
Not applicable (normal, non-tumorigenic primary cell)
Pieteikumi
Adult endothelial model: ox-LDL, leukocyte adhesion, antigen presentation and tumor cell adhesion; Endothelial dysfunction in coronary bypass patients, screening of interventions; Mechanobiology: shear stress and arterial-level stretch in vein graft arterialization; Oxidative stress and mitophagy in vein graft failure; Insulin and IGF-1 receptor signaling in type 2 diabetes; Biomaterials: bioactive wound dressings for chronic wounds
Sinonīmi
  • HSaVEC
  • HSVEC
  • Human saphenous vein endothelial cells
  • provitro 1210121

02Ziedotājs

Donora vecums
Lot-specific (see CoA)
Etniskā piederība
Lot-specific (see CoA)

03Klasifikācija

Organisms
Cilvēks
Sekss
Atkarībā no partijas
Augšanas īpašības
Atbalstītājs
ĢMO statuss
Bez ĢMO
Sīkāka informācija par ĢMO statusu
No genetic modification; primary human endothelial cells isolated from saphenous vein tissue. Not transformed or immortalized.
Bioloģiskās drošības līmenis
1

04Raksturlielumi

Morfoloģija
Cobblestone (endothelial)
Šūnu tips
Primary endothelial cells
Tumorogēns
No
Laiks, kas nepieciešams, lai skaits dubultojās
approx. 24 hours (under optimal EGM-2/EBM-2 conditions, Marelli-Berg et al. 2004)

05Apstrāde un audzēšana

Barotne
Endothelial Cell Growth Medium
Inkubācijas vide

37°C, 5% CO2, saturated humidity.

Papildinājumi
EGM-2-MV BulletKit supplements: hEGF, VEGF, hFGF-B, IGF-1, hydrocortisone, ascorbic acid, heparin, and 5% FBS (pre-formulated in EGM-2; no additional serum needed). Gelatin-coat culture vessels before seeding.
Disociācijas reaģents
Subculture reagents as recommended on the certificate of analysis
Kolbas pārklājums
0.1–0.2% gelatin coating required (incubate gelatin solution 30 min at 37°C, aspirate excess before seeding)
Pārstādīšana

Subculture the cells at about 75 % confluence. Denser cultures undergo irreversible contact inhibition and stop proliferating. Use the subculture reagents recommended on the certificate of analysis.

Sadalījuma attiecība
1 to 3
Sēšanas blīvums
More than 6,000 cells/cm²
Šķidruma atjaunošana
24 hours after seeding, then every 48 to 72 hours
Atgūšanās pēc atkusņa

Post-thaw viability ≥ 70 % viable cells. More than 80 % confluence within the expected recovery period.

Atkausēšana un kultivēšana
  1. Thaw the cryovial quickly in a 37 °C water bath, swirling gently. Just before the last ice has melted, move the vial to a laminar flow hood and decontaminate its outer surface.

  2. Transfer the cell suspension into a 15 ml centrifuge tube, add 10 ml of Endothelial Cell Growth Medium and centrifuge at 250 × g for 5 minutes.

  3. Remove the supernatant and resuspend the cell pellet in 10 ml of Endothelial Cell Growth Medium. Check cell number and viability.

  4. Divide the suspension between two 25 cm² culture flasks (5 ml each). Using two flasks reduces the risk of losing all cells if a passage fails.

  5. Incubate at 37 °C, 5 % CO₂ and saturated humidity, with the screw caps opened by half a turn for gas exchange.

  6. Change the medium after 24 hours to remove unattached cells, then every 48 to 72 hours, using pre-warmed medium only.

  7. Subculture the cells at about 75 % confluence. Denser cultures undergo irreversible contact inhibition and stop proliferating. Use the subculture reagents recommended on the certificate of analysis.

  8. Recommended seeding density: more than 6,000 cells/cm².

06Kvalitātes kontrole un kriokonservācija

Sterilitāte

Mycoplasma contamination is excluded by PCR.

To ensure there is no bacterial, fungal or yeast contamination, cultures are subjected to visual inspection.

Saldēšanas barotne
As a cryopreservation medium, we use complete growth medium + 10% DMSO for adequate post-thaw viability.
Uzglabāšanas nosacījumi

For long-term preservation, store vials in liquid nitrogen at about −150 to −196 °C. Storage at −80 °C is acceptable for up to one week only.

Piegādes nosacījumi

Cryopreserved primary cells are shipped on dry ice. On receipt, check the cryovial for damage and transfer it without delay to appropriate storage.

07Pazīmes un uzņēmība

Virsmas antigēni
CD31 (PECAM-1); VE-cadherin (CD144); von Willebrand factor (vWF); eNOS; HLA-DR (inducible); ICAM-1 (inducible); VCAM-1 (inducible); E-selectin (inducible); UEA-I lectin binding
Ekspresētie receptori
VEGFR2 (KDR); VEGFR1; TIE-2; EGFR (low)

08Identifikatori

Atsauce
Human saphenous vein endothelial cells (HSVEC) (Cytion catalog number 300699)
NCBI nodokļu identifikācijas numurs
9606
Cellosaurus
Not assigned